Home / Sweden / SynAct Pharma AB

SynAct Pharma AB

SE0008241491 Short position disclosed on July 15, 2026.

0.79% of the capital sold short
1 disclosing funds
18 disclosures on record

Funds holding SynAct Pharma AB Titelia

Evolution of the disclosed total

Open positions

History of disclosures

Other companies sold short in Sweden

• Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
• Elekta AB (publ) 10.32% of the capital sold short
• JM AB 7.01% of the capital sold short
• Embracer Group AB 5.83% of the capital sold short
• Hemnet Group AB (publ) 5.59% of the capital sold short
• Truecaller AB 5.43% of the capital sold short
• Bonesupport Holding AB 5.38% of the capital sold short
• Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
• Tobii AB 4.34% of the capital sold short
• Stillfront Group AB (publ) 3.87% of the capital sold short
• Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
• RaySearch Laboratories AB (publ) 3.63% of the capital sold short